Stock APPH APONTIS PHARMA AG
Add to a list
To use this feature you must be a member
Log inSign up

All News Apontis Pharma AG

Equities

APPH

DE000A3CMGM5

Market Closed - Xetra
Other stock markets
 09:06:06 28/06/2024 pm IST 		5-day change 1st Jan Change
8.6 EUR 0.00% Intraday chart for Apontis Pharma AG -0.69% +81.05%
05/04 Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications MT
28/03 Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company
EQ
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management
EQ
DD: APONTIS PHARMA AG: Thomas Milz, buy
EQ
DD: APONTIS PHARMA AG: be executive GmbH, buy
EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy
EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy
EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy
EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy
EQ
DD: APONTIS PHARMA AG: Thomas Zimmermann, buy
EQ
Apontis Pharma : Earnings Call Q1/24 Presentation
PU
APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed
EQ
Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications
MT
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast
EQ
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications
EQ
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Apontis Pharma AG, 2023 Earnings Call, Mar 28, 2024
APONTIS PHARMA expects profitable growth again in 2024
EQ
Apontis Pharma : Earnings Call 2023 Presentation
PU
Transcript : Apontis Pharma AG - Special Call
APONTIS PHARMA successfully completes performance and efficiency improvement program
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APPH Stock
  4. News Apontis Pharma AG